Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Viral vector
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Viral vector
Emergency use authorization Experimental Antiviral Jan/23/2023
Sotrovimab
Viral vector
Emergency use authorization Experimental Antiviral Jul/14/2022
Bamlanivimab
Viral vector
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Viral vector
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Ad26.COV2.S
Viral vector
Emergency use authorization Experimental Vaccine Jun/22/2022
BNT162b2
Viral vector
Approved by FDA Experimental Vaccine Jun/22/2022
Convalescent plasma
Viral vector
Emergency use authorization Experimental Antiviral May/16/2022
ChAdOx1 nCoV-19
Viral vector
Emergency use authorization Experimental Vaccine Jan/04/2022
hrsACE2
Viral vector
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Gam-COVID-Vac
Viral vector
Emergency use authorization Experimental Vaccine Dec/23/2021
ChAd-SARS-CoV-2-S
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
rMVAs
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021
LV::SFL
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020
rVSV-∆G-spike
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020
YF-S0
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/01/2020
sMVA-N/S
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-N
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-S/N
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-S
Viral vector
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020